|
|
|
Insider
Information: |
Hoerter Steven L. |
Relationship: |
|
City: |
Boulder |
State: |
CO |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
83,704 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,228,260 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
83,704 |
|
|
Total
Value |
$2,228,260 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
172.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Clovis Oncology, Inc. |
CLVS |
See Remarks |
2015-03-05 |
0 |
2013-06-04 |
0 |
Premium* |
|
Agios Pharmaceuticals Inc |
AGIO |
Chief Commercial Officer |
2019-03-04 |
10,941 |
2018-01-23 |
0 |
Premium* |
|
Deciphera Pharmaceuticals, Inc. |
DCPH |
|
2023-12-13 |
72,763 |
2019-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
51 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2013-06-04 |
4 |
S |
$73.06 |
$730,600 |
D/D |
(10,000) |
0 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2015-01-13 |
4 |
AS |
$62.00 |
$620,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2015-01-16 |
4 |
AS |
$67.00 |
$670,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2015-02-17 |
4 |
AS |
$72.00 |
$720,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2015-03-05 |
4 |
AS |
$80.00 |
$1,600,000 |
D/D |
(20,000) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
|
2018-01-23 |
4 |
AS |
$74.83 |
$1,870,750 |
D/D |
(25,000) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
|
2018-02-22 |
4 |
AS |
$78.63 |
$161,192 |
D/D |
(2,050) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
|
2018-03-22 |
4 |
AS |
$84.65 |
$173,533 |
D/D |
(2,050) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
|
2018-04-23 |
4 |
AS |
$85.95 |
$176,198 |
D/D |
(2,050) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
|
2018-05-23 |
4 |
AS |
$85.76 |
$175,808 |
D/D |
(2,050) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
|
2018-06-22 |
4 |
AS |
$97.58 |
$200,039 |
D/D |
(2,050) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
|
2018-07-25 |
4 |
AS |
$84.58 |
$173,389 |
D/D |
(2,050) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
|
2018-08-24 |
4 |
AS |
$74.92 |
$153,586 |
D/D |
(2,050) |
0 |
0 |
- |
|
DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
|
2023-03-21 |
4 |
AS |
$15.57 |
$116,782 |
D/D |
(7,500) |
0 |
0 |
% |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
|
2018-02-22 |
4 |
OE |
$39.76 |
$81,508 |
D/D |
2,050 |
2,050 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
|
2018-03-22 |
4 |
OE |
$39.76 |
$81,508 |
D/D |
2,050 |
2,050 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
|
2018-04-23 |
4 |
OE |
$39.76 |
$81,508 |
D/D |
2,050 |
2,050 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
|
2018-05-23 |
4 |
OE |
$39.76 |
$81,508 |
D/D |
2,050 |
2,050 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
|
2018-06-22 |
4 |
OE |
$39.76 |
$81,508 |
D/D |
2,050 |
2,050 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
|
2018-07-25 |
4 |
OE |
$39.76 |
$81,508 |
D/D |
2,050 |
2,050 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
|
2018-08-24 |
4 |
OE |
$39.76 |
$81,508 |
D/D |
2,050 |
2,050 |
0 |
- |
|
DCPH |
Deciphera Pharmaceuticals... |
President and CEO |
|
2023-02-14 |
4 |
AS |
$16.00 |
$480,720 |
D/D |
(30,045) |
7,500 |
0 |
% |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Commercial Officer |
|
2019-01-22 |
4 |
D |
$52.82 |
$304,719 |
D/D |
(5,769) |
9,231 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2013-06-04 |
4 |
OE |
$11.02 |
$110,200 |
D/D |
10,000 |
10,000 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2015-01-13 |
4 |
OE |
$11.02 |
$110,200 |
D/D |
10,000 |
10,000 |
0 |
- |
|
51 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|